BOFFA, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 1.705
Totale 1.705
Nazione #
IT - Italia 1.705
Totale 1.705
Città #
Genova 904
Genoa 465
Rapallo 332
Bordighera 4
Totale 1.705
Nome #
Different MRI patterns in MS worsening after stopping fingolimod 125
Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis 116
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 111
A two alternative forced choice method for assessing vibrotactile discrimination thresholds in the lower limb 109
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 102
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 101
Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of “black holes” 100
Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis? 94
Two-way crossed cerebellar diaschisis in a clinically isolated syndrome suggestive of multiple sclerosis 77
Preserved brain functional plasticity after upper limb task-oriented rehabilitation in progressive multiple sclerosis 68
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 61
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 54
Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal 52
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 51
Impact of highly active immunotherapy on acute and chronic neuroinflammation in aggressive multiple sclerosis 49
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases 49
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab 48
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 41
Long-term clinical outcomes of hematopoietic stem cell transplantation in multiple sclerosis 34
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis 33
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 32
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 32
Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis 31
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 31
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis 28
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic 24
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 23
What happens after fingolimod discontinuation? A multicentre real-life experience 22
Physical exercise moderates the effects of disability on depression in people with multiple sclerosis during the covid-19 outbreak 18
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis 12
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities 11
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 10
Fronto-temporal vulnerability to disconnection in paediatric moderate and severe traumatic brain injury 8
A diffusion tensor magnetic resonance imaging study of paediatric patients with severe non-traumatic brain injury 8
Positron Emission Tomography with [18F]-DPA-714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease Progression 6
The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis 6
Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice 5
Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience 3
The effect of Cladribine and Fingolimod treatments on retinal atrophy 2
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study 1
E200k familial creutzfeldt-jakob disease presenting with subacute multiple cranial neuropathy 1
Totale 1.789
Categoria #
all - tutte 8.098
article - articoli 7.984
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201933 0 0 0 0 0 0 0 0 0 2 8 23
2019/2020386 25 4 15 38 32 64 43 29 46 51 26 13
2020/2021293 14 25 82 48 15 18 7 20 18 24 11 11
2021/2022250 13 4 7 19 8 21 3 59 22 39 12 43
2022/2023407 31 36 5 48 36 55 2 25 54 20 77 18
2023/2024417 20 34 11 53 33 91 120 20 20 15 0 0
Totale 1.789